Breakthrough pancreatic cancer treatment phase III trial opens in Israel

Rafael Pharmaceuticals launched a phase-3 clinical trial on Thursday for pancreatic cancer at eight sites throughout Israel. The primary investigator is Dr. Talia Golan, head of Sheba Medical Center’s Pancreatic Cancer Center. Read the full article by Maayan Jaffe-Hoffman in the Jerusalem Post here.




2019-07-19T12:57:34+00:00July 19th, 2019|Africa, Investment, Israel, Medical, R&D, South Africa|0 Comments